Table 1 Baseline characteristics of study participants

No. of participants, N (% of total)

150 (100%)

Female, N (% of total)

96 (64%)

Age, years

54 (42–61)

Height, cm

162 (157–168)

Weight, kg

64 (55–74)

BMI score

23.5 (21.7–27.0)

No. of smokers, N (% of total)

24 (16%)

No. of participants with medical history, N (% of total)

91 (60.7%)

No. of participants requiring mechanical ventilation during hospitalization, N (% of total)

14 (9.3%)

Hospitalization Days, days

16 (12–24)

Treatment received during hospitalization, N (% of total)

 Antiviral drug

 Interferon treatment

 Antibody product

 Antibody cocktail treatment

 Oxygen support

 Corticosteroids

 Anti-inflammatory drugs

 Immunomodulatory drugs

 Anti-leprosy drug

 Others

43 (28.67%)

33 (22%)

23 (15.33%)

15 (10%)

13 (8.67%)

4 (2.67%)

3 (2%)

2 (1.33%)

1 (0.67%)

9 (6%)

No. of participants who received Chinese medicine consultations prior to study, N (% of total)

150 (100%)

 1 consultation

 2 consultations

 3 consultations

 4 consultations

 5 consultations

 6 consultations

 7 consultations

 8 consultations

 9 consultations

 10 consultations

19 (12.67%)

24 (16%)

27 (18%)

18 (12%)

12 (8%)

10 (6.67%)

6 (4%)

2 (1.33%)

4 (2.67%)

28 (18.67%)